|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
1R01CA190092-01
|
$555,711
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
|
1R01CA184926-01
|
$799,422
|
JAFFEE, ELIZABETH
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
|
7R01CA179991-02
|
$354,825
|
IACOBUZIO-DONAHUE, CHRISTINE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
|
1R21CA185536-01
|
$208,800
|
BHATTACHARYA, PRATIP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
|
1R01CA185357-01
|
$459,341
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQD6) Muscle stem cells and cancer cachexia
|
5R01CA180057-02
|
$357,894
|
GUTTRIDGE, DENIS
|
OHIO STATE UNIVERSITY
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
|
5R01CA170495-03
|
$341,162
|
CAGAN, ROSS
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
|
1R21CA176561-01A1
|
$159,818
|
COLLISSON, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
5K08CA137153-05
|
$163,080
|
COLLISSON, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A novel regimen to target both pancreatic cancer K-ras and antiapoptotic proteins
|
1R03CA182552-01
|
$84,900
|
LI, FENGZHI
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
|
5R21CA178651-02
|
$167,198
|
JACKSON, MARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,076,623
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-05
|
$314,143
|
MAHAJAN, NUPAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
ADAM17 in pancreatic cancer and pancreatitis
|
5R01CA159222-04
|
$378,431
|
CRAWFORD, HOWARD
|
MAYO CLINIC JACKSONVILLE
|
|
Adaptable hydrogel platform to study pancreatic cancer
|
1R21CA188911-01
|
$169,650
|
LIN, CHIEN-CHI
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Adoption and Retooling of GEM model for Pancreatic Cancer
|
ZIA BC 011463
|
$56,483
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Advanced Glycation End-Products and Risk of Pancreatic Cancer
|
5R01CA172880-02
|
$620,623
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advanced Methods to Evaluate Extracellular Matrix and Crosslinking in the Tumor M
|
1R33CA183685-01
|
$386,014
|
HANSEN, KIRK
|
UNIVERSITY OF COLORADO DENVER
|
|
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
|
5R01CA164041-03
|
$310,909
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An epigenetic switch controlling pancreatic cancer susceptibility
|
5R21CA179453-02
|
$161,397
|
MURTAUGH, LEWIS
|
UNIVERSITY OF UTAH
|
|
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
|
1R21CA180764-01A1
|
$221,589
|
LI, FENGZHI
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
An integrated computational and functional genomics discovery engine for preclini
|
5U01CA176303-02
|
$1,013,016
|
KEMP, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Annexin A2 as a mediator of pancreatic cancer metastases
|
5R01CA169702-02
|
$326,066
|
ZHENG, LEI
|
JOHNS HOPKINS UNIVERSITY
|
|
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase
|
5R21CA170995-02
|
$164,034
|
SUN, YI
|
UNIVERSITY OF MICHIGAN
|
|
Anti-PV1 Therapy for Pancreatic Cancer
|
5R21CA172983-02
|
$170,890
|
STAN, RADU
|
DARTMOUTH COLLEGE
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S2
|
$3,835,199
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S3
|
$75,000
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S4
|
$50,000
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$1,066,167
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis
|
5R21CA173348-02
|
$182,799
|
DU, YI-CHIEH NANCY
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Axl as a target for the therapy of pancreatic cancer
|
5R21CA173487-02
|
$167,726
|
BREKKEN, ROLF
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
B Cell Repertoire Molecular Platform for Antibody Drug Discovery
|
1R43CA187852-01
|
$249,077
|
JOHNSON, DAVID
|
GIGAGEN, INC.
|
|
BASE CONTRACT TITLE: PRECLINICAL IN VITRO AND IN VIVO AGENT DEVELOPMENT ASSAYS,
|
261201290020I
|
$1,081,705
|
UNKNOWN, UNKNOWN
|
STATE OF OKLAHOMA:1109502
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors
|
5R01CA051210-22
|
$304,864
|
ROSS, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
|
Biological Activity of Ras Oncogenes
|
5R01CA042978-28
|
$346,184
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
1R01CA182076-01A1
|
$493,395
|
ALLEN, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$358,240
|
Kaplan, Rosandra
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|